159 related articles for article (PubMed ID: 17420212)
1. Lysostaphin in treatment of neonatal Staphylococcus aureus infection.
Oluola O; Kong L; Fein M; Weisman LE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2198-200. PubMed ID: 17420212
[TBL] [Abstract][Full Text] [Related]
2. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
Placencia FX; Kong L; Weisman LE
Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
[TBL] [Abstract][Full Text] [Related]
3. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
[TBL] [Abstract][Full Text] [Related]
4. Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream.
Cui F; Li G; Huang J; Zhang J; Lu M; Lu W; Huang Q
Drug Deliv; 2010 Nov; 17(8):617-23. PubMed ID: 20726810
[TBL] [Abstract][Full Text] [Related]
5. Sustained anti-staphylococcal effect of lysostaphin in the rabbit aqueous humor.
Balzli CL; McCormick CC; Caballero AR; O'Callaghan RJ
Curr Eye Res; 2010 Jun; 35(6):480-6. PubMed ID: 20465441
[TBL] [Abstract][Full Text] [Related]
6. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
McCormick CC; Dajcs JJ; Reed JM; Marquart ME; O'Callaghan RJ
Curr Eye Res; 2006 Mar; 31(3):225-30. PubMed ID: 16531279
[TBL] [Abstract][Full Text] [Related]
8. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Dajcs JJ; Thibodeaux BA; Girgis DO; Shaffer MD; Delvisco SM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3712-6. PubMed ID: 12454041
[TBL] [Abstract][Full Text] [Related]
9. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
Dajcs JJ; Thibodeaux BA; Hume EB; Zheng X; Sloop GD; O'Callaghan RJ
Curr Eye Res; 2001 Jun; 22(6):451-7. PubMed ID: 11584345
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
LaPlante KL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
[TBL] [Abstract][Full Text] [Related]
11. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
[TBL] [Abstract][Full Text] [Related]
12. [Methicillin-resistant Staphylococcus aureus infection and its treatment in burned patients].
Huan JN; Chen YL; Ge SD
Zhonghua Wai Ke Za Zhi; 1994 Apr; 32(4):244-5. PubMed ID: 7842932
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
14. Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.
Hertlein T; Sturm V; Lorenz U; Sumathy K; Jakob P; Ohlsen K
Antimicrob Agents Chemother; 2014; 58(3):1630-8. PubMed ID: 24366730
[TBL] [Abstract][Full Text] [Related]
15. Lysostaphin: an antistaphylococcal agent.
Kumar JK
Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
[TBL] [Abstract][Full Text] [Related]
16. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model.
Windolf CD; Lögters T; Scholz M; Windolf J; Flohé S
PLoS One; 2014; 9(12):e115940. PubMed ID: 25536060
[TBL] [Abstract][Full Text] [Related]
17. Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland.
Bramley AJ; Foster R
Res Vet Sci; 1990 Jul; 49(1):120-1. PubMed ID: 2382049
[TBL] [Abstract][Full Text] [Related]
18. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.
Oldham ER; Daley MJ
J Dairy Sci; 1991 Dec; 74(12):4175-82. PubMed ID: 1787188
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
20. [Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice].
Huan JN
Zhonghua Wai Ke Za Zhi; 1992 May; 30(5):270-1, 316. PubMed ID: 1289000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
